|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao A, Guo L, Xu J, Zheng L, Guo Z, Ling
Z, Wang L and Mao W: Identification and validation of circulating
exosomes-based liquid biopsy for esophageal cancer. Cancer Med.
8:3566–3574. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qin HD, Liao XY, Chen YB, Huang SY, Xue
WQ, Li FF, Ge XS, Liu DQ, Cai Q, Long J, et al: Genomic
characterization of esophageal squamous cell carcinoma reveals
critical genes underlying tumorigenesis and poor prognosis. Am J
Hum Genet. 98:709–727. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhong R, Chen Z, Mo T, Li Z and Zhang P:
Potential role of circPVT1 as a proliferative factor and treatment
target in esophageal carcinoma. Cancer Cell Int. 19:2672019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang W, Hong R, Li L, Wang Y, Du P, Ou Y,
Zhao Z, Liu X, Xiao W, Dong D, et al: The chromosome 11q13. 3
amplification associated lymph node metastasis is driven by
miR-548k through modulating tumor microenvironment. Mol Cancer.
17:1252018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tkach M and Théry C: Communication by
extracellular vesicles: Where we are and where we need to go. Cell.
164:1226–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ludwig S, Floros T, Theodoraki MN, Hong
CS, Jackson EK, Lang S and Whiteside TL: Suppression of lymphocyte
functions by plasma exosomes correlates with disease activity in
patients with head and neck cancer. Clin Cancer Res. 23:4843–4854.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsu MC and Hung WC: Pyruvate kinase M2
fuels multiple aspects of cancer cells: From cellular metabolism,
transcriptional regulation to extracellular signaling. Mol Cancer.
17:352018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao X, Wang H, Yang JJ, Liu X and Liu ZR:
Pyruvate kinase M2 regulates gene transcription by acting as a
protein kinase. Mol Cell. 45:598–609. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang P and Li Z, Fu R, Wu H and Li Z:
Pyruvate kinase M2 facilitates colon cancer cell migration via the
modulation of STAT3 signalling. Cell Signal. 26:1853–1862. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Buschow SI, Van Balkom BW, Aalberts M,
Heck AJ, Wauben M and Stoorvogel W: MHC class II-associated
proteins in B-cell exosomes and potential functional implications
for exosome biogenesis. Immunol Cell Biol. 88:851–856. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li L, Zhang Y, Qiao J, Yang JJ and Liu ZR:
Pyruvate kinase M2 in blood circulation facilitates tumor growth by
promoting angiogenesis. J Biol Chem. 289:25812–25821. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang P and Li Z, Wang Y, Zhang L, Wu H and
Li Z: Secreted pyruvate kinase M2 facilitates cell migration via
PI3K/Akt and Wnt/β-catenin pathway in colon cancer cells. Biochem
Biophys Res Commun. 459:327–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai J, Escara-Wilke J, Keller JM, Jung Y,
Taichman RS, Pienta KJ and Keller ET: Primary prostate cancer
educates bone stroma through exosomal pyruvate kinase M2 to promote
bone metastasis. J Exp Med. 216:2883–2899. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sudo N, Ichikawa H, Muneoka Y, Hanyu T,
Kano Y, Ishikawa T, Hirose Y, Miura K, Shimada Y, Nagahashi M, et
al: Clinical utility of ypTNM stage grouping in the 8th edition of
the American joint committee on cancer TNM staging system for
esophageal squamous cell carcinoma. Ann Surg Oncol. 28:650–660.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Muller L, Hong CS, Stolz DB, Watkins SC
and Whiteside TL: Isolation of biologically-active exosomes from
human plasma. J Immunol Methods. 411:55–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei P, Wu F, Kang B, Sun X, Heskia F,
Pachot A, Liang J and Li D: Plasma extracellular vesicles detected
by single molecule array technology as a liquid biopsy for
colorectal cancer. J Extracell Vesicles. 9:18097652020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo J, Liu L, Shen J, Zhou N, Feng Y,
Zhang N, Sun Q and Zhu Y: MiR-576-5p promotes
epithelial-to-mesenchymal transition in colorectal cancer by
targeting the Wnt5a-mediated Wnt/β-catenin signaling pathway. Mol
Med Rep. 23:942021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan Y, Xu Z, Huang J, Guo G, Gao M, Kim W,
Zeng X, Kloeber JA, Zhu Q, Zhao F, et al: The deubiquitinase USP36
Regulates DNA replication stress and confers therapeutic resistance
through PrimPol stabilization. Nucleic Acids Res. 48:12711–12726.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu S, Zhang Y, Li Q, Zhang Z, Zhao G and
Xu J: CLDN6 promotes tumor progression through the YAP1-snail1 axis
in gastric cancer. Cell Death Dis. 10:9492019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang W, Ou X and Wu X: Proteomics
profiling of plasma exosomes in epithelial ovarian cancer: A
potential role in the coagulation cascade, diagnosis and prognosis.
Int J Oncol. 54:1719–1733. 2019.PubMed/NCBI
|
|
23
|
Matsumoto Y, Kano M, Akutsu Y, Hanari N,
Hoshino I, Murakami K, Usui A, Suito H, Takahashi M, Otsuka R, et
al: Quantification of plasma exosome is a potential prognostic
marker for esophageal squamous cell carcinoma. Oncol Rep.
36:2535–2543. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McKiernan J, Donovan MJ, O'Neill V,
Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A,
Andriole G, et al: A novel urine exosome gene expression assay to
predict high-grade prostate cancer at initial biopsy. JAMA Oncol.
2:882–889. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Severino V, Dumonceau JM, Delhaye M, Moll
S, Annessi-Ramseyer I, Robin X, Frossard JL and Farina A:
Extracellular vesicles in bile as markers of malignant biliary
stenoses. Gastroenterology. 153:495–504. e8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dorayappan KDP, Wanner R, Wallbillich JJ,
Saini U, Zingarelli R, Suarez AA, Cohn DE and Selvendiran K:
Hypoxia-induced exosomes contribute to a more aggressive and
chemoresistant ovarian cancer phenotype: A novel mechanism linking
STAT3/Rab proteins. Oncogene. 37:3806–3821. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma Z, Cui X, Lu L, Chen G, Yang Y, Hu Y,
Lu Y, Cao Z, Wang Y and Wang X: Exosomes from glioma cells induce a
tumor-like phenotype in mesenchymal stem cells by activating
glycolysis. Stem Cell Res Ther. 10:602019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei Y, Wang D, Jin F, Bian Z, Li L, Liang
H, Li M, Shi L, Pan C, Zhu D, et al: Pyruvate kinase type M2
promotes tumour cell exosome release via phosphorylating
synaptosome-associated protein 23. Nat Commun. 8:140412017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang C, Wang J, Chen Z, Gao Y and He J:
Immunohistochemical prognostic markers of esophageal squamous cell
carcinoma: A systematic review. Chin J Cancer. 36:652017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiaoyu H, Yiru Y, Shuisheng S, Keyan C,
Zixing Y, Shanglin C, Yuan W, Dongming C, Wangliang Z, Xudong B and
Jie M: The mTOR pathway regulates PKM2 to affect glycolysis in
esophageal squamous cell carcinoma. Technol Cancer Res Treat.
17:15330338187800632018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma R, Liu Q, Zheng S, Liu T, Tan D and Lu
X: PKM2-regulated STAT3 promotes esophageal squamous cell carcinoma
progression via TGF-β1-induced EMT. J Cell Biochem. 2019.(Epub
ahead of print). View Article : Google Scholar
|
|
32
|
Liu Q, Liang M, Liu T, Vuitton L, Zheng S,
Gao X, Lu M, Li X, Sheyhidin I and Lu X: M2 isoform of pyruvate
kinase (PKM2) is upregulated in Kazakh's ESCC and promotes
proliferation and migration of ESCC cells. Tumour Biol.
37:2665–2672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, Liu T, Zheng S, Liu Q, Shen T,
Han X, Zhang Q, Yang L and Lu X: SUMOylation of HSP27 regulates
PKM2 to promote esophageal squamous cell carcinoma progression.
Oncol Rep. 44:1355–1364. 2020.PubMed/NCBI
|
|
34
|
Zhang Z, Deng X, Liu Y, Liu Y, Sun L and
Chen F: PKM2, function and expression and regulation. Cell Biosci.
9:522019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li S, Huang P, Gan J, Ling X, Du X, Liao
Y, Li L, Meng Y, Li Y and Bai Y: Dihydroartemisinin represses
esophageal cancer glycolysis by down-regulating pyruvate kinase M2.
Eur J Pharmacol. 854:232–239. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song J, Sun T, Tang Z, Ruan Y, Liu K, Rao
K, Lan R, Wang S, Wang T and Liu J: Exosomes derived from smooth
muscle cells ameliorate diabetes-induced erectile dysfunction by
inhibiting fibrosis and modulating the NO/cGMP pathway. J Cell Mol
Med. 24:13289–13302. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hrustincova A, Krejcik Z, Kundrat D,
Szikszai K, Belickova M, Pecherkova P, Klema J, Vesela J, Hruba M,
Cermak J, et al: Circulating small noncoding RNAs have specific
expression patterns in plasma and extracellular vesicles in
myelodysplastic syndromes and are predictive of patient outcome.
Cells. 9:7942020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hou PP, Luo LJ, Chen HZ, Chen QT, Bian XL,
Wu SF, Zhou JX, Zhao WX, Liu JM, Wang XM, et al: Ectosomal PKM2
promotes HCC by inducing macrophage differentiation and remodeling
the tumor microenvironment. Mol Cell. 78:1192–1206. e10. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tanaka Y, Kamohara H, Kinoshita K,
Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M and Baba H:
Clinical impact of serum exosomal microRNA-21 as a clinical
biomarker in human esophageal squamous cell carcinoma. Cancer.
119:1159–1167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Noguchi T, Inoue H and Tanaka T: The
M1-and M2-type isozymes of rat pyruvate kinase are produced from
the same gene by alternative RNA splicing. J Biol Chem.
261:13807–13812. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu J, Hu L, Chen M, Cao W, Chen H and He
T: Pyruvate kinase M2 overexpression and poor prognosis in solid
tumors of digestive system: Evidence from 16 cohort studies. Onco
Targets Ther. 9:4277–4288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Y, Li Y, Jiang L, Ren X, Cheng B and
Xia J: Prognostic value of glycolysis markers in head and neck
squamous cell carcinoma: A meta-analysis. Aging (Albany NY).
13:7284–7299. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Haura EB, Turkson J and Jove R: Mechanisms
of disease: Insights into the emerging role of signal transducers
and activators of transcription in cancer. Nat Clin Pract Oncol.
2:315–324. 2005. View Article : Google Scholar : PubMed/NCBI
|
